1. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors;Bocan;Biochim Biophys Acta,1992
2. Single- and multiple-dose pharmacokinetics of CI-981, a potent HMG-CoA reductase inhibitor (abstract);Whitfield;Pharm Res,1993
3. Safety, tolerance and pharmacokinetic profiles following single doses of CI-981, a potent HMG-CoA reductase inhibitor (abstract);Cilla;Pharm Res,1993
4. The physiological disposition of lovastatin;Duggan;Drug Metab Dispos,1989
5. Metabolic disposition studies on simvastatin, a cholesterol lowering prodrug;Vickers;Drug Metab Dispos,1990